Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  11/21/2007
 
Trade Name:  Omnaris Nasal Spray
 
Generic Name or Proper Name (*):  ciclesonide
 
Indications Studied:  Treatment of seasonal allergic rhinitis (SAR) in patients 6 through less than 12 years of age
 
Label Changes Summary:  Indication extended down to 6 years of age Pediatric dosing information provided Two clinical studies evaluated safety in children 6 to 11 years of age and the overall incidence of adverse events was comparable to those treated with placebo Efficacy in children 2 to 5 years of age was not established in clinical trials conducted in this age group. Waiver of studies in children ages 0 to less than 2 years of age for SAR because of local and systemic safety concerns as well as lack of disease and/or diagnosis difficulties in children New indication
 
Product Labeling:  Labeling  Opens a new window
 
PREA(P):  P
 
Sponsor:  Nycomed US Inc.
 
NNPS:  FALSE'
 
Therapeutic Category:  Antiasthmatic; antiallergy
 
-
-